Le Lézard
Classified in: Health, Science and technology

Introduction to the In-Vitro Diagnostic Regulation (IVDR) Online Training Course (November 3-4, 2022) - ResearchAndMarkets.com


The "Introduction to the In-Vitro Diagnostic Regulation (IVDR) Training Course" conference has been added to ResearchAndMarkets.com's offering.

The In-Vitro Diagnostic Regulation (EU) 2017/746, which came into force in May 2017 with a transition period of five years, is intended to strengthen the current approval system for in-vitro diagnostics and makes substantial changes to the existing IVD Directive (98/79/EC) legislation.

The Regulation introduces a new risk-rule classification system based on the Global Harmonization Task Force (GHTF) rules which, for the first time, takes patient impact into consideration. This will have a significant impact on all manufacturers of IVDs as about 80 per cent of all devices will now require some form of conformity assessment by a Notified Body.

This seminar will clarify the requirements applicable to in-vitro diagnostic devices under the new Regulation, highlight the major changes to responsibility and product data expectations and provide a thorough understanding of the impact on the industry.

Practical workshops over the two days will help consolidate the information provided.

Who Should Attend:

Key Topics Covered:

Introduction to IVDs

Historical overview of the current IVD Directive (98/79/EC)

Introduction to IVD Regulation (EU) 2017/746

Notified Bodies

IVD Regulation - key changes

Compiling the technical documentation for an IVD

Labelling requirements and strategies

ISO 13485:2016

Risk-based classification

Workshop: Product classification

Risk management

Workshop: Risk management

Clinical evidence and common specifications

Vigilance and PMS

Case studies: Reporting/recalls

Key timelines and practical considerations

Discussion: Preparing a roadmap for transition

Speakers:

Nancy Consterdine
Consultant
UL, IVDeology Ltd

Nancy Consterdine. This MDTI expert is a joint director in her own consultancy specialising in global regulatory affairs strategy and compliance for in vitro diagnostics and medical devices, focusing on the transition to the new IVD/Medical Device Regulations, MDSAP and ISO13485:2016.

She has over 30 years in the IVD industry and in previous roles has been responsible for designing, reviewing and maintaining regulatory frameworks for self-declared and annex II list products. Also identifying regulatory strategies around global submissions (EU, FDA, Health Canada, TGA, Russia, Latin America and China). She has a special interest in labelling and UDI requirements.

Stuart Angell
Director
IVDeology Ltd

Stuart Angell. This MDTI expert is a joint director in his own consultancy specialising in global regulatory affairs strategy and compliance for in vitro diagnostics and medical devices focusing on the transition to the new IVD/Medical Device Regulations, MDSAP and ISO13485:2016.

He has over 15 years in the IVD industry and in previous roles has been responsible for designing, reviewing and maintaining regulatory frameworks for self-declared and annex list II products including technical documentation for EU and global submissions (FDA, Health Canada, TGA, Russia, Latin America). He has an excellent understanding of risk management, Post Market Surveillance (PMS) and vigilance.

For more information about this conference visit https://www.researchandmarkets.com/r/van985

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


These press releases may also interest you

at 07:15
IDU, a leading provider of Financial Budgeting, Modelling, Consolidation and Reporting solutions, today announced its integration with the Sage Intacct cloud financial management system. IDU has also been listed as a certified Sage Intacct...

at 07:15
Service Express, a global data center solutions provider, today announces the full integration of its 2021 U.K. acquisitions of Blue Chip and The ICC Group. Merging the three companies combines decades of expertise and over 1,000 talented individuals...

at 07:14
Today, PartnerVine launched access to UBS' regulatory know-how on the Swiss Financial Services Act ("FinSA"), Financial Institutions Act ("FinIA") and revised Collective Investment Schemes Act ("revCISA"). The products have been prepared by UBS to...

at 07:13
Elandas, Inc., a SaaS-based configurable technology solutions provider, announced it has merged with long-standing partner AccessSync, LLC, a US-based strategic market access execution services provider. Together, Elandas and AccessSync leadership...

at 07:10
NotCo, the food-tech unicorn disrupting plant-based innovation with its proprietary AI technology (Giuseppe), announced a new set of patents for its ability to develop scents and aromas that conjure human emotions and memories. The patents were...

at 07:10
TD SYNNEX today announced financial results for the fiscal second quarter ended May 31, 2022.   Q2 FY22 Q1 FY22(2) Q2 FY21 Net Change from Q1 FY22 Net Change from Q2 FY21 Revenue ($M) $ 15,270   $ 15,470  ...



News published on 16 may 2022 at 10:30 and distributed by: